MET and renal cell carcinoma: In RCC, the activating mutation of MET in hereditary papillary RCC provides well-known evidence, and MET expression induced by hypoxia-inducible factors (HIFs) in clear-cell RCC (ccRCC) is also common evidence [15,16].